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Ovine pulmonary adenocarcinoma (OPA) is an infectious lung tumor of sheep caused by Jaagsiekte sheep
retrovirus (JSRV). To test the hypothesis that JSRV insertional mutagenesis is involved in the oncogenesis of
OPA, we cloned and characterized 70 independent integration sites from 23 cases of OPA. Multiple integration
sites were identified in most tumors. BLAST analysis of the sequences did not disclose any potential oncogenic
motifs or any identical integration sites in different tumors. Thirty-seven of the integration sites were mapped
to individual chromosomes by PCR with a panel of sheep-hamster hybrid cell lines. Integration sites were
found on 20 of the 28 sheep chromosomes, suggesting a random distribution. However, four integration sites
from four different tumors mapped to chromosome 16. By Southern blot hybridization, probes derived from two
of these sites mapped to within 5 kb of each other on normal sheep DNA. These sites were found within a single
sheep bacterial artificial chromosome clone and were further mapped to only 2.5 kb apart, within an unchar-
acterized predicted gene and less than 200 kb from a mitogen-activated protein kinase-encoding gene. These
findings suggest that there is at least one common integration site for JSRV in OPA and add weight to the
hypothesis that insertional mutagenesis is involved in the development of this tumor.
Jaagsiekte sheep retrovirus (JSRV) is the etiological agent
of ovine pulmonary adenocarcinoma (OPA), a naturally occur-
ring lung cancer of sheep (also known as sheep pulmonary
adenomatosis or Jaagsiekte) (26, 39). OPA is characterized by
a lung adenocarcinoma originating from the differentiated ep-
ithelial cells of the distal respiratory tract (8). It is one of the
major infectious diseases of sheep, and lately it has also
emerged as a unique large-animal model for lung cancer (11,
28). OPA is experimentally reproducible by the inoculation of
either lung secretions obtained from OPA-affected animals
(38, 40) or JSRV infectious molecular clones (9, 26).
JSRV is unique among replication-competent retroviruses
in its ability to transform cells in vitro via the expression of its
viral envelope (Env), which functions essentially as an oncop-
rotein (19). Transfection of rodent or chicken fibroblasts with
expression plasmids or vectors for JSRV Env results in the
appearance of classic foci of transformed cells in days or weeks
after transfection. Several studies have investigated the mech-
anisms of JSRV Env-induced cell transformation in vitro (2, 3,
6, 7, 18, 29, 32, 41). Hyaluronidase-2, which is encoded by a
putative tumor suppressor gene, is the cellular receptor for
JSRV (32), and both receptor-dependent (7) and -independent
(6) mechanisms of transformation have been suggested. Acti-
vation of the phosphatidylinositol 3-kinase/Akt pathway medi-
ated by the JSRV Env transmembrane domain helps but is not
essential for transformation of rodent or chicken fibroblasts (3,
18, 29, 41).
The mechanisms by which JSRV induces type II pneumo-
cytes and Clara cells to become adenocarcinomas have not
been studied in detail. Tumorigenesis is a multistep process,
and the expression of JSRV Env might not be sufficient to
transform these cells in vivo. The JSRV long terminal repeats
(LTRs) are specifically active in the cells that are the target for
viral transformation (21, 27). Abundant viral antigens are
present in the tumor cells, and infectious virus is present in the
lung secretions of OPA-affected animals (24, 31). Thus, JSRV
replicates in type II pneumocytes and Clara cells, and this
could allow the viral LTR to activate nearby genes through the
classical mechanism of insertional activation used by most on-
cogenic retroviruses (4, 33). Insertional activation may conse-
quently be part of or ultimately be the cause of JSRV-induced
carcinogenesis in vivo.
Only two JSRV integration sites have previously been cloned
(9, 26), both by screening of genomic DNA libraries. One, from
an OPA tumor cell line, JS7, was in the pulmonary surfactant
protein A gene. The other, from an OPA tumor, was unchar-
acterized because of repetitive elements in the clone. The
analysis of the JSRV insertion sites is greatly complicated by
the presence in the sheep genome of approximately 20 copies
of endogenous retroviruses highly related to JSRV (10, 30).
In this study, to accelerate the identification and isolation of
integration sites, we developed a multistep gene-walking tech-
nique, called low-stringency–high-stringency (ls/hs) PCR, with
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which we cloned 70 JSRV integration sites from 23 sheep and
also the integration site from the JS7 OPA tumor cell line (15).
The chromosomal locations of 37 of these integration sites
were determined by PCR by using as the template DNA iso-
lated from a panel of sheep-hamster somatic hybrid cells, each
containing 1 or a few of the 28 sheep chromosomes. By this
method, the two previously published integration sites also
were mapped to individual chromosomes. Sequences aligning
to the same chromosome were mapped further by Southern
blotting on sheep genomic DNA. Our data suggest that there
is a common integration site for JSRV on chromosome 16 in
tumor DNA extracted from two sheep with OPA. We mapped
this common integration site to chromosome 5q11.2 on the
human genome map. This agrees with the somatic cell hybrid
mapping of the integration sites, as sheep chromosome 16 is
syntenic to HSA5. Further investigation is required to deter-
mine the importance of this site in OPA pathogenesis.
MATERIALS AND METHODS
Source of tumor tissue. Nineteen sheep clinically affected with OPA were
donated by farmers in Scotland. The diagnosis of OPA was confirmed by gross
and histological examination of lungs. An additional four sheep had experimen-
tally induced OPA (38). These animals had multiple smaller nodules, and disease
was not clinically apparent. Kidney and lung tumor samples were collected with
separate sterile instruments to avoid possible cross-contamination, snap-frozen
in liquid nitrogen, and stored at 70°C.
Preparation of DNA. DNA was prepared as described previously (35). Briefly,
kidney and lung tissues were ground to a powder in liquid nitrogen, lysed by
addition to TES (0.01 M Tris, 0.1 M EDTA, 0.5% sodium dodecyl sulfate [SDS]),
digested with 100 g of RNase per ml and 100 g of proteinase K per ml, and
extracted with phenol, pH 8.0. DNA was precipitated with sodium acetate and
isopropanol, washed twice with 70% ethanol, and then resuspended in 0.01 M
Tris–0.1 M EDTA. Cell lines were trypsinized, washed in 1 phosphate-buffered
saline, lysed in TES, and then processed as described above.
ls/hs PCR. ls/hs PCR is a simple, multistep gene-walking PCR technique that
can be used to amplify unknown flanking sequence even when other typical
methods have been unsuccessful. Briefly, the target copy number was increased
by unidirectional amplification with a sequence-specific primer DNA. Next, the
target was subjected to primary amplification with a gene-specific primer in
combination with an NSP under low-stringency conditions. This primary reaction
mixture then underwent reamplification with the same NSP in conjunction with
a second nested, gene-specific primer under conditions of high stringency. Am-
plification products were separated on an agarose gel, Southern blotted, and
hybridized with a gene-specific probe to allow identification of bands that spe-
cifically correspond to extended sequence.
Nonspecific PCR primers (NSPs), i.e., primers not specific for sheep or viral
sequences (donated by other projects at Moredun Research Institute) were used
in conjunction with JSRV-specific primers (Table 1) that had been selected and
optimized for specificity to ensure that they amplified JSRV and not JSRV-
related endogenous virus sequences. For each PCR described below, the reaction
mixtures contained 1 pmol of each primer (MWG-biotech), 50 mM KCl, 10 mM
Tris-HCl (pH 9), 0.1% Triton X-100, 2 mM MgCl2, 200 M each deoxynucleo-
side triphosphate (Roche), and 1.25 U of Taq polymerase (Promega) in a 50-l
volume. The ls/hs PCR technique was conducted as follows (Fig. 1). (i) Thirty
cycles of unidirectional amplification were carried out with primer U3P1r with
100 ng of lung tumor DNA as the template. Cycles were 94°C for 30 s, 58°C for
30 s, and 72°C for 2 min. (ii) Five microliters of the product was used as the
template for a series of PCRs with primer U3P2r together with one of 21
different NSPs. Conditions were 35 cycles of 94°C for 30 s, 30°C for 30 s, and 72°C
for 2 min. (iii) One microliter of the product of this low-stringency PCR was used
as the template for a heminested PCR with primer U3P3r plus the same NSP
used in the previous round. Conditions were 35 cycles of 94°C for 30 s, 58°C for
30 s, and 72°C for 2 min. (iv) A portion of the PCR product was run on a 1%
agarose gel that was then Southern blotted and hybridized with a U3 probe
generated by PCR with digoxigenin labeling mixture (Roche) with primers
U3P5f and U3P4r. Conditions were 35 cycles of 94°C for 30 s, 58°C for 30 s, and
72°C for 40 s. An alkaline phosphatase–nitroblue tetrazolium–5-bromo-4-chloro-
3-indolylphosphate (BCIP) detection system (Roche) was used to identify posi-
tive bands in accordance with the manufacturer’s instructions. The rest of the
product was run on a separate gel, and the positive bands were matched and
recovered. (v) The specificity of the gel-purified amplimers was checked by U3
PCR (with primers U3P5f and U3P4r) and env-U3 PCR (with primers envP6f
and U3P4r). Conditions for both were 35 cycles of 94°C for 30 s, 58°C for 30 s,
and 72°C for 40 s. (vi) Products that were U3 positive and env-U3 negative were
reamplified with primer U3P4r together with the appropriate NSP and then
TABLE 1. Primers used in this study
Primer Sequence
ls/hs PCR non-specific
primers
NSP1 ..........................................CTTTATAGCTTCATCATGCAG
NSP2 ..........................................CTTCCATGGAGGCGTGAA
NSP3 ..........................................GAGATCCTCGCATGGATC
NSP4 ..........................................GCTCGCCTGTGGTCCTGATA
NSP5 ..........................................GAAGACGCTTACAGACTACC
NSP6 ..........................................ATGAAATACTTGGTGCTGGC
NSP7 ..........................................CAGCGATGACAAGATACGCG
NSP8 ..........................................ATGAGGTACAACGTAGTTGC
NSP9 ..........................................CATCCATGTGGACATCATGG
NSP10 ........................................AGGACGCTTACGAATTACCG
NSP11 ........................................TTGACCTTCGGCTATGAGTA
NSP12 ........................................GTTCAAGCTTGTCCAGGAATTC
NSP13 ........................................CTAGTACTGGTACCATGTCTGC
NSP14 ........................................TTAGCAATCCGGCGCCCT
NSP15 ........................................AGCTCGAAATTAACCCTCAC
NSP16 ........................................CTGATTGAGATCTGACGC
NSP17 ........................................ACTCAAGCATTTCCTCACAAGGCAC
NSP18 ........................................CTAGTACTGGTACCATGTCTGCAGC
CAAGG
NP19 ..........................................TCGGTGAGCCGGTGAAA
NP20 ..........................................ATGTCCTCGCTGGACAC
NP21 ..........................................GGGAATTCAATGGTTGCAGCCATG
ls/hs PCR JSRV-specific
primers
U3P1r ........................................CACCGGATTTTTACACAATCACCGG
U3P2r ........................................CAATGCCAAAAGCAAACATCCG
U3P3r ........................................ATTTCCTGRTATTTCTGTGAAGC
U3P4r ........................................CAGCAAACATCCGAACCTTAAGAG
JSRV LTR probe-
labeling PCR
U3P5f.........................................CGATCGATGCGGGGGACGACC
U3P4r ........................................CAGCAAACATCCGAACCTTAAGAG
JSRV env-LTR PCR
envP2f ........................................CACTCCTTGGACTTTATGTCGAG
U3P4r ........................................CAGCAAACATCCGAACCTTAAGAG
JSRV-specific LTR PCR
U3P1f.........................................TGGGAGCTCTTTGGCAAAAGCC
U3P1r ........................................CACCGGATTTTTACACAATCACCGG
Flanking region probe-
labeling PCRs
171/5af .......................................AAATGCTGTGGGTGAGATTC
171/5ar .......................................TTGTGAGAGACATGGGAATAG
175/10f .......................................ACCAAATCTGAGAAAACGAGC
175/10r .......................................GAGTTGGGAAATTTTCGTG
177/7f .........................................GGAAACATTGAGTGTCTTGGG
177/7r .........................................CCAAAAAGACCTGCCTCCTTA
178/3f .........................................CTGCAATGGCCACACAGCGT
178/3r .........................................CCAACCAAGGAATCGAACC
Integration site PCR
U3P4r ........................................CAGCAAACATCCGAACCTTAAGAG
U3P1r ........................................CACCGGATTTTTACACAATCACCGG
177/7n1 ......................................TCTCAACCTGACTCTGTGGTGC
177/7n2 ......................................CCAAAAAGACCTGCCTCCTTA
175/10n1 ....................................GAGTTGGGAAATTTTCGTG
175/10n2 ....................................CATTGTTTCCAGAGAGTTGG
VOL. 78, 2004 INTEGRATION SITES OF JSRV IN OPA 8507
cloned into pGemTeasy (Promega) in accordance with the manufacturers in-
structions. Plasmids were sequenced on an ABI 377 DNA sequencer (Applied
Biosystems) with ABI Dye terminator chemistry. The sequences were compared
to each other with the Vector NTI suite. Flanking region sequences, i.e., free of
JSRV U3 or NSP sequences, were submitted for a BLASTn search (www.ncbi
.nlm.nih.gov) both with and without repetitive sequences masked with Repeat-
Masker (http://ftp.genome.washington.edu/RM/RepeatMasker.html).
Integration site PCR on sheep-hamster somatic cell hybrid lines. The inte-
gration site sequences were used to design primers to amplify a unique sequence
within the sheep genome, avoiding repetitive sequences identified by Repeat-
Masker. Each primer pair was further optimized by gradient PCR (Mastercycler
Gradient; Eppendorf). A 50-l reaction mixture consisted of 350 ng of genomic
DNA, 1 PCR buffer (Sigma), 200 M each deoxynucleoside triphosphate
(Sigma), 20 pmol of each primer, and 1.5 U of Taq polymerase (Sigma). The
thermocycler was programmed for an initial cycle of 94°C for 3 min; 30 cycles of
94°C for 30 s, variable temperature depending on the primer pair for 30 s, and
72°C for 30 s; and then a final extension of 72°C for 5 min. PCR products of
greater than 200 bp were separated in 1.5% agarose, and those of less than 200
bp were separated by 6% polyacrylamide gel electrophoresis in 1 Tris-borate-
EDTA. The genomic DNA was prepared from a panel of 30 sheep-hamster
somatic hybrid cell lines obtained from the Eleanor Roosevelt Institute, Denver,
Colo. A full description of the cell lines and their selection media was published
previously (5).
Southern hybridization. For Southern blot analysis of the chromosome 16
integration sites, genomic DNA from the lung of an uninfected sheep was
cleaved with the restriction endonuclease BamHI, EcoRI, PstI, or SacI (Fig. 2).
Panels of digests (10 g per lane) were separated on a 0.7% agarose gel and
transferred to nylon membrane (MSI, Westborough, Mass.) with a PosiBlot
30-30 Pressure Blotter (Stratagene). [-32P]dCTP-labeled DNA probes were
generated by PCR with primer pairs specific for the flanking regions of clones
175/10, 177/7, 178/3, and 171/5 (Table 1). Each membrane was hybridized singly
and in combination with the [-32P]dCTP-labeled 175/10, 177/7, 178/3, and 171/5
probes with a probe (UltraHyb; Ambion) specific activity of 106 cpm/ml at 42°C.
Following hybridization, the membranes were washed at 42°C twice for 5 min
(2 SSC [1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate], 0.1% SDS) and
then twice for 15 min (0.1% SSC, 0.1% SDS), followed by either exposure to a
PhosphorImager screen (Kodak) or autoradiography. By the same methods,
Southern blots of uninfected sheep lung DNA were hybridized with probes for
the integration sites that mapped to chromosome 6 singly and then in combina-
tion. Southern blots of lung tumor and kidney DNAs from four different animals
and of DNAs from two different tumor cell lines (15) were hybridized with the
177/7 probe essentially as described above except that hybridization and washes
were performed at 62°C.
Integration site PCR. The primers used for integration site PCR were nested
primers (n1 and n2 in Table 1) chosen from the integration site flank regions
together with primer U3P4r. PCRs were performed with plasmid, kidney, or lung
tumor DNA as the template. Touchdown PCR was done as follows: 94°C for 30 s,
65°C for 30 s (decreasing by 0.4°C per cycle), and 72°C for 30 s for 35 cycles. In
order to confirm our results and rule out contamination, the PCR assays were
repeated with an exogenous specific primer (U3P1r) from outside the cloned
integration sites together with the nested flank primers. This PCR could only be
positive for genuine integration sites and could not amplify our clones or previ-
ous PCR product.
Screening of an ovine BAC library. An ovine bacterial artificial chromosome
(BAC) library (12) was screened by three rounds of PCR with primers 175/10 and
177/7 as described previously. Briefly, the first PCR was of 78 superpools, each
of which contained DNAs from eight plates of 96 BAC clones. In the second
round, eight single pools, representing DNAs from each of the eight plates in the
positive superpool, were screened. Finally, the pooled row and column DNAs
from the positive plate were screened. The intersection of the row and column
identified the location of the positive BAC clone. A single colony of the positive
clone was used to inoculate a 50-ml culture in Luria broth containing 12.5 g of
chloramphenicol per ml. After incubation with shaking at 37°C for 18 h, BAC
DNA was extracted by standard alkaline lysis (35) and resuspended in 50 l of
Tris-EDTA. A PCR product was generated with 1 l of BAC DNA as the
template and, for verification, sequenced by ABI Dye terminator chemistry.
The selected BAC was subcloned into pBluescript following digestion with
PstI, and colonies were picked at random for shotgun sequencing. The sequence
data were analyzed by BLASTn to anchor the BAC to the draft human sequence.
Nucleotide sequence accession numbers. The nucleotide sequences greater
than 50 bp long determined in this study have been submitted to the GenBank
database and assigned accession no. AY322366 to AY322426.
RESULTS AND DISCUSSION
We developed a highly sensitive and specific multiround
ls/hs PCR technique that enabled us to clone 70 JSRV inte-
gration sites from OPA tumor tissue of 23 different sheep
(Table 2). The validity of the clones could be confirmed be-
cause they contained 152 bp of U3 sequence uniquely identi-
fying JSRV. The length of the flanking region (host cell DNA)
ranged from 12 to 671 bp. Sequences of greater than 50 bp
were deposited in the GenBank database. The sequences less
than 60 bp long were too short for mapping to individual
FIG. 1. Schematic diagram of the ls/hs PCR technique used to
amplify JSRV integration sites.
FIG. 2. Southern blot analysis of sheep DNA hybridized with chro-
mosome 16 integration sites 175/10 and 177/7 showing colocalization of
these two sites. Each lane consists of 10 g of genomic DNA digested
with BamHI (B), EcoRI (E), PstI (P), or SacI (S). The first panel was
hybridized with flank probe 175/10, the second was hybridized with
177/7, and the third was hybridized with both probes. The molecular
weight (MW) standard is HindIII-digested phage lambda DNA.
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chromosomes by PCR assay. Nevertheless, they were informa-
tive regarding the presence of multiple unique integration sites
in individual tumors. Multiple integration sites were shown to
occur in most (15 of 23) of the OPA tumors. This is the same
as for mouse mammary virus (MMTV)-induced tumors, which
contain multiple (2 to 20) exogenous MMTV proviruses at
different sites in the genome (22). OPA tumors 179 and 180
were completely negative with NSPs 1 to 14. Subsequently,
additional NSPs (15 to 21) were used that did facilitate the
amplification of multiple integration sites from these tissues.
Application of the ls/hs PCR and blotting technique to nontu-
mor tissue (n 3) did not result in any positive bands (data not
shown), demonstrating the specificity of this method.
BLAST analysis of the 70 sequences amplified from LT
DNA did not reveal any significant alignment with known
oncogenic sequences. Of the 70 integration sites, 22 (31%)
aligned with repetitive sequences. At least 30 to 40% of the
sheep genome consists of repeat sequences, so this cannot be
interpreted as a preference to integrate into these regions.
There was no bias of any particular NSP for repetitive se-
quences. Thirty-eight of the sequences had no significant
matches with any sequences in the databases (only segments of
35 bp), and 10 integration sites aligned with fairly short
regions (50 to 100 bp) of human or bovine sequence. At the
sheep genome-JSRV junction there was no apparent bias for
any particular nucleotide or nucleotide pattern.
To localize each integration site, including JSRV JS7 and
JSRV 21 (9, 26), to a specific sheep chromosome, a PCR assay
was performed with integration site-specific primers and tem-
plate DNA from each of 30 sheep-hamster somatic hybrid cell
lines (5), as well as CHO cell and normal sheep DNAs as
negative and positive controls, respectively. It could not be
determined from the available chromosome distribution on
cell lines whether 172/3 mapped to chromosome 12 or 15.
Three sites, 171/5b, 172/10, and 173/7, were PCR positive on
our normal sheep DNA but did not map to a specific chromo-
some. Therefore, these may represent sequences that are
present in the source DNA and our control but vary at one or
both primer sites in the genome from which the cell lines are
derived. Alternatively, one or more chromosomes or particular
chromosome fragments are not represented in the panel of
hamster-sheep hybrids. Integration sites 170/5a and 172/6
mapped to both hamster and sheep chromosomes, suggesting
that the PCR detects a sequence common to both genomes.
Nine of the original integration sites were uninformative owing
to repeat sequences throughout the clones. Even though 11 of
39 integration sites were mapped to just two chromosomes
(namely, 6 and 16), statistical analysis by a likelihood ratio test
did not confirm any preference for a particular chromosome.
Indeed, the distribution of integration sites among the sheep
chromosomes was similar to that predicted by the Poisson
distribution (5 hits per chromosome, 0.5 predicted, 1 actual;
4 hits, 1.5 predicted, 1 actual; 3 hits, 3.8 predicted, 3 actual;
2 hits, 7 predicted, 5 actual; 1 hit, 9 predicted, 9 actual; 0 hits,
6 predicted, 8 actual).
Five of the six integration sites assigned to single human
chromosomes by BLASTn were assigned to a syntenic sheep
chromosome (14) by the somatic cell hybrid mapping. For
example, site 39/7 aligned with human chromosome 14, which
is syntenic with sheep chromosomes 7 and 18.
TABLE 2. JSRV integration site clones obtained from OPA
Integration
site
(animal/
NSP)
Flanking
region
size
(bp)
BLAST result summarya Chromo-some
24/7 142 Rpt (Bov-tA SINE)
24/8 193 Rpt (human L2) 3
37/5 289 Rpt (Bov-B LINE)
37/9 270 No matches 23 10
39/7 300 Human chr, 14 	220 18
39/8 671 Rpt (Bov-tA & -A2 SINE) 7
39/12 280 Human 	80 bp (1 chr) 2
68/3 406 Rpt (Bov-B LINE)
168/1 169 Human chr 7 	80 bp 4
170/5a 155 Bos taurus 	80 bp CHO
170/5b 121 No matches 20 bp
170/7 81 Rpt ( satellite) 6
170/12 38 Rpt 7
171/1 367 Rpt (human Mariner 	120 bp) 3
171/4 184 No matches 30 bp
171/5a 115 Human 	40 bp (1 chr) 16
171/5b 105 No matches 30 bp
171/5c 75 No matches 20 bp 14
171/7a 218 No matches 30 bp 6
171/7b 175 No matches 30 bp 3
171/9a 169 Rpt seqs 	50 bp 13
171/9b 27 No matches 20 bp
171/11a 161 Human chr 12 (PCCX2 gene) 	60 bp 17
171/11b 140 Rpt ( satellite)
171/11c 56 No matches 20 bp
172/1 386 Human chr 10 	80 bp 21
172/3 217 No matches 20 bp 12 or 15
172/4 53 No matches 20 bp
172/6 108 No matches 27 bp CHO
172/7b 189 Human 	35 bp 20
172/7c 165 Human 	35 bp 10
172/7d 123 No matches 20 bp 6
172/10 78 No matches 20 bp
172/12 73 Human chr 14 	50 bp 18
173/7 466 Rpt (Bov-B)
173/10 339 Rpt (Bov SINE)
174/3 87 No matches 30 bp 5
174/10 72 No matches 20 bp 1
175/7a 12 No matches 20 bp
175/7b 84 Rpt 	30 bp (SINE) 11
175/7c 182 Rpt (Bov-tA SINE)
175/9 233 Rpt (Bov-A2 SINE) X
175/10 90 Human chr 5 	60 bp 16
177/5a 22 No matches 20 bp
177/5b 131 Rpt (human L1)
177/7 246 No matches 20 bp 16
178/3 268 Rpt (Bov-tA SINE) 16
179/18 144 No matches 20 bp
179/19 165 No matches 20 bp
179/20a 430 No matches 20 bp
179/20b 316 No matches 20 bp
180/17a 30 No matches 20 bp
180/17b 69 No matches 20 bp
180/19 87 No matches 20 bp
180/20a 129 Rpt ( satellite)
180/20b 126 No matches 20 bp
180/21 168 No matches 30 bp
184/3 307 Rpt (Bov-A2 SINE)
184/6 423 Rpt (Bov-2 SINE) 13
184/7 519 Human chr 8 	110 bp 26
184/11 351 No matches 20 bp 2
187/6a 296 Human 	50 bp (1 chr) 17
187/6b 342 No matches 20 bp 7
192/10 95 No matches 20 bp 1
506/4 47 No matches 20 bp
e158M/6 34 No matches 20 bp
e159M/5 42 No matches 20 bp
e138G/9 98 No matches 20 bp 6
e139G/7 345 Rpt (Bov-A2, -1D SINE) 26
e139G/10 352 Rpt (Bov-2 SINE)
JS7/18 37 Surfactant protein A 10
JSRV21 No matches 6
a Rpt, repetitive; chr, chromosome; seqs, sequences.
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In order to identify potential common integration loci,
probes from different integration sites were hybridized to nor-
mal sheep DNA. Chromosomes with more than three integra-
tion sites were selected, and by this approach, evidence for a
common integration site on chromosome 16 was obtained.
Blots of normal sheep genomic DNA were hybridized singly
and in combination with probes of 175/10 and 177/7 integration
sites (Fig. 2). The BamHI and PstI bands were identical, and
both had the same-size EcoRI band, with 177/7 having an
additional band of 5 kb, which is suspected to be a restriction
fragment length polymorphism in this restriction site in the
normal sheep DNA. The hybridization of both probes to a
single PstI fragment of approximately 4.5 kb showed that these
two integration sites map less than 4.5 kb apart. A SacI restric-
tion site is apparently situated between the two integration
sites, as they hybridize with different SacI fragments. The other
two chromosome 16 integration sites did not seem to have the
same banding pattern by Southern blot analysis and, as a result,
were not further analyzed. The five integration sites on chro-
mosome 6 did not have any identical bands, indicating that
these integrations did not occur near each other (data not
shown).
The proximity of integration sites 175/10 and 177/7 was con-
firmed by their presence in a single BAC clone selected from
an ovine BAC library by PCR. Further, both sites were present
in a 4.5-kb subfragment of this BAC clone (GenBank accession
number AY523942). Sequence analysis showed that the inte-
gration sites were 2,535 bp apart (Fig. 3a), and the presence of
PstI, EcoRI, and SacI restriction sites was in agreement with
the information obtained by Southern hybridization (Fig. 2).
A BLASTn analysis of sequences from subclones of the
BAC clone aligned it against National Center for Biotechnol-
ogy Information Build 33 of the human genome sequence to
HSA5 (Fig. 3b). The 175/10 and 177/7 integration sites fall in
a predicted gene, LOC345648, on human chromosome 5. No
function has been assigned to this gene. Other predicted genes
lie close to this region. Of particular interest, MAP3K1 lies less
than 200 kb away from the integration sites. This is within the
range of distances previously reported for enhancer activation
of cellular oncogenes by retrovirus LTRs (16). In addition,
mitogen-activated protein kinase activation has been demon-
strated in OPA tumor cells in vivo by immunohistochemistry
(M. De las Heras, personal communication, 2003).
In order to determine if integrations in this region of chro-
mosome 16 occur in more tumors than 177 and 175, Southern
blots of lung tumor and kidney DNAs from four sheep were
hybridized with a probe corresponding to integration site
177/7. However, this did not reveal an additional band in lung
tumor DNA compared to kidney DNA, which would have
indicated a clonal population of cells. A novel 6-kb band hy-
bridizing in HindIII-digested lung tumor, but not kidney, DNA
of all four animals was found to be lung specific rather than
tumor specific, suggesting that integration 177/7 is in a region
specifically methylated in lung DNA and not kidney DNA.
Digests of lung tumor DNA with six other restriction enzymes,
including ones that are unaffected by methylation, did not
reveal a second band, even in DNA from tumor 177. These
findings suggested that the proportion of tumor cells that con-
tained integrated JSRV was below the level of detection by
Southern hybridization.
Subsequent PCR analysis showed that the 177/7 integration
site was not present in DNA extracted from other parts of the
FIG. 3. Ovine BAC (OBAC) clone 383R6C1 contains integration sites 175/10 and 177/7. (a) Schematic diagram of BAC subclone (GenBank
accession no. AY523942) showing PstI, SacI, and EcoRI restriction sites in relation to the integration sites. Arrows indicate the orientation of the
two integration sites. (b) Alignment of the BAC clone with the orthologous HSA5q11.2 genomic sequence represented according to Build 33 of
the human genome sequence according to the National Center for Biotechnology Information (www.ncbi.nlm.nih.gov/mapview). Predicted genes
are in dark grey, and confirmed genes are in light grey. Boxes indicate the relative positions of BLASTn hits from randomly sequenced BAC
subclones.
8510 COUSENS ET AL. J. VIROL.
same tumor. It could be amplified from plasmid, but unfortu-
nately none of the original tumor DNA from which the clone
was amplified remained. PCR amplification of integration site
175/10 revealed its presence only in the DNA from which the
site was originally cloned (Fig. 4). Two other DNA samples
from lung tumor of the same animal were negative. Thus, the
PCRs showed that the integration sites were clonal only in a
small area of the tumor. This result was verified with a primer
in JSRV U3 downstream of any of the integration site clones to
confirm that the positive results were not due to contamination
with any previous PCR product or plasmid.
In summary, two integration sites from different OPA cases
were found only 2.5 kb apart on the genome, an event with a
probability of approximately 106 if integration is completely
random, compared to 1 in 20 in this study (i.e., 2 integrations
of 40 mapped to individual chromosomes). This supports a role
for insertional mutagenesis. In order to strengthen this hypoth-
esis, further evidence of integration sites in this region is re-
quired, which requires generation and analysis of additional
JSRV integration sites. In addition, comparative expression
studies for the genes close to this region would be of great
interest in assessing the role of these integrations.
Neither of these insertion sites was found to be clonal, sug-
gesting that (i) the integration sites we have identified are not
involved in tumorigenesis but are accumulated during tumor
growth or viral replication or (ii) multiple tumors arise inde-
pendently but nevertheless may contain integration sites in a
preferred area, as occurs in MMTV-induced tumors. The dis-
covery that JSRV tumors are polyclonal or oligoclonal does
not argue against insertional mutagenesis, as multiclonality has
also been reported for tumors induced by MMTV (36). It is
clear that the host genetic background has a strong effect on
the frequency with which a particular gene is insertionally
activated in MMTV tumors. For instance, in CH3 mice wnt-1
is activated in 75% of tumors while in other mouse strains this
value is 25 to 59% (20). OPA affects an outbred sheep popu-
lation; therefore, analysis of greater numbers of tumors is
required to identify additional preferred sites.
As has been shown for other retrovirus-induced tumors (1,
13, 17, 34), OPA development is likely to be a multistep pro-
cess resulting from an accumulation of events that may not
necessarily need to occur in a specific order. The recent data
on the transforming activity of the transmembrane envelope
protein in vitro (2, 3, 6, 7, 18, 29, 32, 41) suggest an important
but not necessarily exclusive role for acute transformation by
JSRV. In particular, an acute transformation mechanism does
not fit with the long incubation periods between infection and
tumor production seen in natural OPA, especially as no im-
mune response to JSRV is detectable in infected animals (23,
25; C. Summers, personal communication). We suggest that
proliferation of alveolar type II cells or a precursor target cell,
induced by the JSRV envelope protein, may be a step in the
tumorigenic pathway but that insertional mutagenic events also
may be necessary.
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